A Study to Allow Continued Dosing and/or Follow-up of Patients Who Have Had Previous Exposure to Poziotinib
Clinical trial NCT03744715 · TERMINATED
Trial details
- NCT number
- NCT03744715
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-11
- Primary completion
- 2023-03-03
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.